BAYER AKTIENGESELLSCHAFT «...678910...» Page 6 out of 137 from 01/07/1988 to 07/08/2024 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 20/03/2019 10:53 BAYER AKTIENGESELLSCHAFT Legal disputes Bayer statement on jury´s decision in phase one of California glyphosate trial Register number: 276246 08/03/2019 08:04 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer submits European marketing authorization application for darolutamide Register number: 275801 05/03/2019 15:49 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer submits darolutamide for marketing authorization in Japan Register number: 275717 05/03/2019 07:50 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer submits darolutamide for marketing authorization in Japan Register number: 275670 01/03/2019 16:04 BAYER AKTIENGESELLSCHAFT Announcements and resolutions of general shareholders meetings Annual General Meeting, Bayer AG: AGM Notice 2019 Register number: 275630 27/02/2019 11:06 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer AG: Corporate Governance Report 2018 Register number: 275236 27/02/2019 11:01 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer AG: Public Information refered to "Resultatos 2018" Register number: 275235 27/02/2019 08:07 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer increases sales and earnings – leader in agriculture after acquisition Register number: 275205 27/02/2019 08:03 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer: Q4 2018 Analyst and Investor Briefing Register number: 275203 27/02/2019 08:00 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer completes rolling submission for darolutamide in U.S. Register number: 275202 Page 6 out of 137 «...678910...»